Snapshot
Investments
News
Gallery
FAQs

Rahul Agrawal Snapshot

Rahul Agrawal

Rahul Agrawal

Chief Medical Officer and Head of R&D

Organization

lock starlock starlock starlock starlock star

Social Links

Birth & Early Life

Physical Status

Male

Education

Careers

Personal Details

Married

Rahul Agrawal Investments

Total no. of Investment

1

Rahul Agrawal has made 1 investments.

DateCompanySectorRoundInvestmentsCo-Investors
2019-03-20Technologyseed₹ 2.4 Cr

Rahul Agrawal Frequently Asked Questions (FAQs)

Cereno Scientific AB is a clinical-stage biotech company that develops treatments for cardiovascular diseases,Cereno Scientific develops treatments for rare and common cardiovascular diseases, including those with thrombosis, fibrosis, high pressure, and inflammation.

Cereno Scientific's B share (CRNO B) has been traded on Nasdaq First North Growth Market since June 2023.

Cereno Scientific's headquarters are in AstraZeneca's BioVenture Hub in Sweden.

  • Dr. Agarwal expressed his excitement about joining Cereno Scientific, highlighting the company’s promising drug candidate portfolio and platform aimed at transforming treatment for cardiovascular diseases.
  • He noted that Cereno's focus on pulmonary arterial hypertension (PAH) and thrombosis prevention could lead to a significant shift in patient care.
  • He emphasized the portfolio's potential for reverse remodelling in PAH and its ability to prevent thrombosis without the associated bleeding risks, which he considers highly clinically relevant.

Is This Your Account?

Unlock the full potential of your online presence! If you recognise this account, time to claim it and take control. Seize the opportunity now and own your digital space.